Status:
COMPLETED
The Impact of Noradrenaline on Ventriculo-arterial Coupling and Central Cardiovascular Energy Delivery
Lead Sponsor:
St. Olavs Hospital
Conditions:
Heart Diseases
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The study aims to examine how noradrenaline in combination with venous return influences the energy transmission from heart to central circulation and arteries - also called arterio-ventricular coupli...
Detailed Description
After being informed about the study 40 elective CABG patients with written informed consent will undergo assessment of their arterio-ventricular coupling postoperatively after coronary bypass graft s...
Eligibility Criteria
Inclusion
- elective coronary artery bypass graft surgery
- requirement for Noradrenaline/Norepinephrine
Exclusion
- lack of informed consent
- patient unsuitable for mean arterial pressure (MAP) elevation of 20mmHg
- patient requiring different blood pressure range due to medical/surgical needs
- poor image quality due to patient factors
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT04745845
Start Date
March 1 2021
End Date
December 31 2021
Last Update
January 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Olavs Hospital, Dep. for Anesthesia & Intensive care. Section of cardiothoracic Anesthesia and -intensive Care.
Trondheim, Norway, 7006